Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants

Author's Avatar
Sep 27, 2021

Study population mirrors diversity of US demographics and findings demonstrate that whole genome sequencing should be considered a first-line test for patients with suspected genetic disease

PR Newswire